Daimler Truck Q2 Profit Falls 18%, 2026 Outlook Raised 
Asian Stocks Mixed as Chip Selloff Hits KOSPI, Nikkei Ahead of US Jobs Data 
US Dollar Gains as Iran Tensions, Fed Rate Hike Bets Rise 
Delta Flight Makes Emergency Landing in Atlanta After Cockpit Fumes Reported 
Mercedes-Benz Stock Offers Deep-Value Potential as Citi Sees Recovery Catalysts 
Oil Prices Rise as Hormuz Reopening Remains Uncertain 
US Dollar Near Two-Month Low as Markets Await Inflation Data 
Yes, government influences wages – but not just in the way you might think 
AI is driving down the price of knowledge – universities have to rethink what they offer 
Office design isn’t keeping up with post-COVID work styles - here’s what workers really want 
6 simple questions to tell if a ‘finfluencer’ is more flash than cash 
Glastonbury is as popular than ever, but complaints about the lineup reveal its generational challenge 
China Inflation Cools in July as CPI Misses Forecast, PPI Deflation Eases 
Japan Posts First Current Account Deficit in 17 Months as Dividend Payments Surge 
Asian Currencies Steady as Markets Await U.S. Jobs Data 
Airbnb Stock Jumps After Q2 Earnings Beat, Strong 2026 Outlook 
Meta Ordered to Pay $567M Over Child Safety Violations in New Mexico 
Hindustan Unilever (HUL) will invest in Zywie Ventures (OZiva) and Nutritionalab (Wellbeing Nutrition) to enter the health and well-being business category.
Unilever’s Indian subsidiary will initially acquire a 51 percent equity stake in OZiva, before purchasing the rest in three years.
A plant-based and clean-label consumer wellness brand, OZiva supplies lifestyle protein, hair and beauty supplements, and women’s health solutions.
OZiva’s current team will continue to operate all business functions.
Meanwhile, HUL is buying a 19.8 percent interest in Wellbeing Nutrition. The company’s product range includes marine collagen powder, Melts oral strips and health capsules. The current Wellbeing Nutrition team, led by founder and CEO Avnish Chhabria, will continue to operate the business.
According to Sanjiv Mehta, HUL’s CEO and managing director, the strategic investments give them an entry into the fast-growing health and wellbeing category.
Mehta added that HUL is well-positioned to support further scale-up of these businesses through our R&D, market development, distribution capabilities, and Unilever’s global health and wellbeing expertise.
Both transactions are set for completion within three months.
